Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

Among the solute carrier (SLC) superfamily, the cystine/glutamate transporter system antiporter components SLC3A2 and ... Here, we use a targeted CRISPR-Cas9 screen of the SLC superfamily to identify ...

Southwest United Graduate School, Yunnan Key Laboratory of Cell Metabolism and Diseases, State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan Center for Life Sciences, ...

Jan. 15, 2025 — New observational data and simulation models have confirmed a new type of planet unlike anything found in the Solar System. This provides another piece of the puzzle to ...

* To avoid being charged the recurring subscription fee, simply cancel before the free-trial period ends — it's just $4.99 a month afterwards. The go-to solution for ultimate PC performance and ...

In this model, plectin deficiency suppresses tumor initiation and growth. We further demonstrate that CRISPR/Cas9-engineered human HCC cell lines with inactivated plectin display limited migration, ...